Tomas Koltai

903 total citations
24 papers, 456 citations indexed

About

Tomas Koltai is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Tomas Koltai has authored 24 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Tomas Koltai's work include Cancer, Hypoxia, and Metabolism (7 papers), Enzyme function and inhibition (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Tomas Koltai is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Enzyme function and inhibition (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Tomas Koltai collaborates with scholars based in Italy, Argentina and Canada. Tomas Koltai's co-authors include Rosa Angela Cardone, Stephan J. Reshkin, Tiago M. A. Carvalho, Maria Raffaella Greco, Khalid O. Alfarouk, Larry Fliegel, Victor Rodov, S. Ben‐Yehoshua, Barbara Rolando and Natalia Prevarskaya and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Seminars in Cancer Biology.

In The Last Decade

Tomas Koltai

23 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomas Koltai Italy 10 225 198 116 70 69 24 456
Pinjiang Cao Canada 11 327 1.5× 176 0.9× 87 0.8× 91 1.3× 74 1.1× 16 518
Asieh Emami Nejad Iran 4 228 1.0× 140 0.7× 207 1.8× 78 1.1× 128 1.9× 5 499
Marjan Taherian Iran 5 217 1.0× 141 0.7× 201 1.7× 83 1.2× 129 1.9× 10 525
Mojtaba Ahmadlou Iran 3 218 1.0× 138 0.7× 207 1.8× 77 1.1× 128 1.9× 6 489
Simin Najafgholian Iran 3 236 1.0× 150 0.8× 213 1.8× 83 1.2× 134 1.9× 5 516
Yamin Zhang China 13 344 1.5× 139 0.7× 139 1.2× 98 1.4× 79 1.1× 26 561
Kalliopi Domvri Greece 12 231 1.0× 113 0.6× 146 1.3× 108 1.5× 44 0.6× 18 430
Mojgan Esparvarinha Iran 7 254 1.1× 152 0.8× 205 1.8× 103 1.5× 129 1.9× 9 580
Antje Lindemann United States 9 315 1.4× 210 1.1× 130 1.1× 35 0.5× 87 1.3× 12 536

Countries citing papers authored by Tomas Koltai

Since Specialization
Citations

This map shows the geographic impact of Tomas Koltai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Koltai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Koltai more than expected).

Fields of papers citing papers by Tomas Koltai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Koltai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Koltai. The network helps show where Tomas Koltai may publish in the future.

Co-authorship network of co-authors of Tomas Koltai

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Koltai. A scholar is included among the top collaborators of Tomas Koltai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Koltai. Tomas Koltai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carvalho, Tiago M. A., Maria Raffaella Greco, Rosanna Mallamaci, et al.. (2024). Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its Sensitivity to Gemcitabine and C18-Gemcitabine. Cells. 13(9). 730–730. 4 indexed citations
2.
Reshkin, Stephan J., Rosa Angela Cardone, & Tomas Koltai. (2024). Genetic Signature of Human Pancreatic Cancer and Personalized Targeting. Cells. 13(7). 602–602. 7 indexed citations
3.
Koltai, Tomas & Larry Fliegel. (2024). Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts. Pharmaceuticals. 17(6). 744–744. 7 indexed citations
4.
Koltai, Tomas & Larry Fliegel. (2024). Exploring monocarboxylate transporter inhibition for cancer treatment. SHILAP Revista de lepidopterología. 5(1). 135–169. 7 indexed citations
5.
Koltai, Tomas & Larry Fliegel. (2023). Fructose, Another Sweet for Cancer: A Context Acting Nutrient Hypothesis. Gene Expression. 22(2). 141–155. 3 indexed citations
6.
Koltai, Tomas. (2023). Earlier Diagnosis of Pancreatic Cancer: Is It Possible?. Cancers. 15(18). 4430–4430. 8 indexed citations
7.
Koltai, Tomas & Larry Fliegel. (2023). The Relationship between Trop-2, Chemotherapeutic Drugs, and Chemoresistance. International Journal of Molecular Sciences. 25(1). 87–87. 9 indexed citations
8.
Koltai, Tomas. (2022). The complex relationship between multiple drug resistance and the tumor pH gradient: a review. Cancer Drug Resistance. 5(2). 277–303. 17 indexed citations
9.
Koltai, Tomas, Stephan J. Reshkin, & Rosa Angela Cardone. (2022). Resistance to antiangiogenic treatments: A review. Elsevier eBooks. 147–197. 2 indexed citations
10.
Koltai, Tomas, Stephan J. Reshkin, Tiago M. A. Carvalho, et al.. (2022). Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. Cancers. 14(10). 2486–2486. 67 indexed citations
11.
Koltai, Tomas, Stephan J. Reshkin, Tiago M. A. Carvalho, & Rosa Angela Cardone. (2021). Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer. International Journal of Molecular Sciences. 22(8). 3953–3953. 11 indexed citations
12.
Carvalho, Tiago M. A., Maria Raffaella Greco, Tomas Koltai, et al.. (2021). Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches. Cancers. 13(23). 6135–6135. 49 indexed citations
13.
Koltai, Tomas. (2020). The Ph paradigm in cancer. European Journal of Clinical Nutrition. 74(S1). 14–19. 26 indexed citations
14.
Koltai, Tomas. (2020). Targeting the pH Paradigm at the Bedside: A Practical Approach. International Journal of Molecular Sciences. 21(23). 9221–9221. 12 indexed citations
15.
Koltai, Tomas, Rosa Angela Cardone, & Stephan J. Reshkin. (2019). Synergy Between Low Dose Metronomic Chemotherapy and the pH-Centered Approach Against Cancer. International Journal of Molecular Sciences. 20(21). 5438–5438. 5 indexed citations
16.
Koltai, Tomas. (2017). Triple-edged therapy targeting intracellular alkalosis and extracellular acidosis in cancer. Seminars in Cancer Biology. 43. 139–146. 10 indexed citations
17.
Koltai, Tomas. (2017). Tumor heterogeneity: An overlooked issue in cancer therapeutics. Zenodo (CERN European Organization for Nuclear Research). 4(2). 1 indexed citations
18.
Koltai, Tomas. (2016). Cancer: fundamentals behind pH targeting and the double-edged approach. OncoTargets and Therapy. Volume 9. 6343–6360. 79 indexed citations
19.
Koltai, Tomas. (2014). Clusterin: a key player in cancer chemoresistance and its inhibition. OncoTargets and Therapy. 7. 447–447. 124 indexed citations
20.
Rodov, Victor, et al.. (2003). Testing Perforated Heat-Shrinkable Films and Carbon Dioxide Absorbers for Packaging of "Tommy Atkins" Mango. Advances in Horticultural Science. 1000–1008. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026